ZURCHER KANTONALBANK FINANCE (GUERNSEY) LIMITED | Market Closed - Swiss Exchange 11:20:00 2024-06-25 EDT | ||
| 101 USD | +0.18% |
|
| Current month | +1.79% | ||
| 1 month | +1.22% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-25 | 101 | +0.18% |
| 24-06-24 | 100.8 | +0.40% |
| 24-06-21 | 100.4 | +0.18% |
| 24-06-20 | 100.2 | +0.14% |
| 24-06-19 | 100 | +0.50% |
Delayed Quote Swiss Exchange
Last update June 25, 2024 at 11:20 am
More quotesStatic data
| Product type | Certificati Altri |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | ZKB |
| Z09KMZ | |
| ISIN | CH1329133974 |
| Date issued | 2024-05-14 |
| Maturity | 2025-05-14 (323 Days) |
| Parity | 0.25 : 1 |
| Emission price | 100 $ |
| Emission volume | N/A |
| Settlement | entrambi |
| Currency | USD |
Technical Indicators
| Highest since issue | 101 $ |
|---|---|
| Lowest since issue | 99.17 $ |
| Spread | 7 $ |
| Spread % | 0.69% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
319.3
USD
Average target price
316.4
USD
Spread / Average Target
-0.90%
- Stock Market
- Certificates
- Z09KMZ Certificat
